Omega Diagnostics Group PLC Update on proposed Share Reorganisation (1341L)
September 01 2023 - 5:29AM
UK Regulatory
TIDMODX
RNS Number : 1341L
Omega Diagnostics Group PLC
01 September 2023
Omega Diagnostics Group plc
('Omega' or the 'Company')
Update on proposed Share Reorganisation
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health and Nutrition products,
announces an update with regards its proposed Share Reorganisation
as notified in the Company's Notice of Annual General Meeting,
which was posted to shareholders on 11 August 2023.
Proposed Share Reorganisation
Having consulted with a number of shareholders post the
announcement of 31 August, the board has decided not to proceed
with the proposed Share Reorganisation and associated consolidation
of the Ordinary Shares. The board will withdraw Resolution 8 set
out in the Notice of AGM with regards the Share Reorganisation.
Accordingly, the issued share capital of the Company will remain
unchanged at 237,685,180 ordinary shares of 4 pence each and
123,245,615 deferred shares of 0.9 pence each.
The Company remains well funded and the Directors reiterate that
they have no need or intention to raise funds at this time.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
finnCap Ltd Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore
(Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584
391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company
focused on industry-leading Health and Nutrition products.
www.omegadx.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CARLBMLTMTTMMRJ
(END) Dow Jones Newswires
September 01, 2023 05:29 ET (09:29 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Aug 2023 to Aug 2024